Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents

JACC: Cardiovascular Interventions

Volumn 3, Issue 5, 2010, Pages 531-539

  Guagliumi, Giulio ^a   Musumeci, Giuseppe ^a   Sirbu, Vasile ^a   Bezerra, Hiram G ^b   Suzuki, Nobuaki ^b   Fiocca, Luigi ^a   Matiashvili, Aleksandre ^a   Lortkipanidze, Nikoloz ^a   Trivisonno, Antonio ^a   Valsecchi, Orazio ^a   Biondi Zoccai, Giuseppe ^c   Costa, Marco A ^b  

^a OSPEDALI RIUNITI   (Italy)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

coronary artery disease; optical coherence tomography; percutaneous transluminal coronary angioplasty; stent

Indexed keywords

PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS; CARDIOVASCULAR AGENT; DRUG DERIVATIVE; METAL;

ADULT; AGED; ARTICLE; BARE METAL STENT; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG ELUTING STENT; FOLLOW UP; HUMAN; HYPERPLASIA; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; NEOINTIMA; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ANGIOCARDIOGRAPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CORONARY BLOOD VESSEL; ENDOSCOPIC ECHOGRAPHY; FEASIBILITY STUDY; FEMALE; INSTRUMENTATION; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; PROSTHESIS; STENT; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; FEASIBILITY STUDIES; FEMALE; HUMANS; HYPERPLASIA; MALE; METALS; MIDDLE AGED; PACLITAXEL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; SIROLIMUS; STENTS; TIME FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77954746572     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2010.02.008     Document Type: Article

References (15)

1. Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med 2006;119:1056-61.
2. Finn AV, Joner M, Nakazawa G, et al. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothe-lialization. Circulation 2007;115:2435-41.
3. Cook S, Wenaweser P, Togni M, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 2007;115:2426-34.
4. Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193-202.
5. Balakrishnan B, Tzafriri AR, Seifert P, et al. Strut position, blood flow and drug deposition: implications for single and overlapping drug-eluting stents. Circulation 2005;111:2958-65.
6. Finn AV, Kolodgie FD, Harnek J, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus-or paclitaxel-eluting stents. Circulation 2005;112:270-8.
7. Suzuki Y, Ikeno F, Koizumi T, et al. In vivo comparison between optical coherence tomography and intravascular ultrasound for detecting small degrees of in-stent neointima after stent implantation. J Am Coll Cardiol Intv 2008;1:168-73.
8. Matsumoto D, Shite J, Shinke T, et al. Neointimal coverage of sirolimus-eluting stents at 6 month follow-up evaluated by optical coherence tomography. Eur Heart J 2007;28:961-7.
9. Guagliumi G, Sirbu V. Optical coherence tomography: high resolution intravascular imaging to evaluate vascular healing after coronary stent-ing. Catheter Cardiovasc Interv 2008;72:237-47.
10. Costa MA, Angiolillo DJ, Tannenbaum M, et al. Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial). Am J Cardiol 2008;101:1704-11.
11. Kawaguchi R, Sabate M, Angiolillo DJ, et al. Angiographic and 3D intravascular ultrasound assessment of overlapping bare metal stent and three different formulations of drug-eluting stents in patients with diabetes mellitus. Int J Cardiovasc Imaging 2008;24:125-32.
12. Mintz G. Features and parameters of drug-eluting stent deployment discoverable by intravascular ultrasound. Am J Cardiol 2007;100 Suppl:26M-35M.
13. Cutlip DE, Windecher S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definition. Circulation 2007;115:2344-51.
14. Tsagalou E, Chieffo A, Iakovou J, et al. Multiple overlapping drug-eluting stents to treat diffuse disease of the left anterior descending coronary artery. J Am Coll Cardiol 2005;45:1570-3.
15. Finn AV, Nakazawa G, Joner M, et al. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 2007;27:1500-10.